[Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001711:Biotransformation; D002908:Chronic Disease; D004987:Ethers / Q000378:metabolism / Q000494:pharmacology; D005632:Fructose / Q000627:therapeutic use; D006207:Half-Life; D006506:Hepatitis A / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism* / Q000494:pharmacology; D008107:Liver Diseases / Q000378:metabolism*; D008875:Middle Aged; D011743:Pyrimidines / Q000378:metabolism* / Q000494:pharmacology; D006435:Renal Dialysis; D013053:Spectrophotometry; D013449:Sulfonamides / Q000378:metabolism* / Q000494:pharmacology; D014044:Tolbutamide / Q000378:metabolism* / Q000494:pharmacology; D000637:Transaminases / Q000097:blood; D010837:Vitamin K 1 / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D004987:Ethers; D007004:Hypoglycemic Agents; D011743:Pyrimidines; D013449:Sulfonamides; D014815:Vitamins; D005632:Fructose; D010837:Vitamin K 1; D014044:Tolbutamide; D000637:Transaminases